Ionis Pharmaceuticals Inc (NASDAQ:IONS)
| 48.65 Delayed Data As of Dec 08 |  -0.78 / -1.58%Today’s Change | 32.69 Today|||52-Week Range 51.89 | +28.81% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 128.8M | 84.7M | 129.6M | 278.8M | |
| Short Term Investment Cash | -14.2M | -44.1M | 44.9M | 149.2M | ||
| Cash & Short Term Investments | 804.0M | 667.6M | 1.0B | 2.1B | ||
| Receivables | Receivables | 11.4M | 108.0M | 63.0M | 12.8M | |
| Inventories | Inventories | 6.9M | 7.5M | 10.0M | 8.6M | |
| Current Assets | Other Current Assets | 14.8M | 14.8M | 72.3M | 101.1M | |
| Current Assets | 837.0M | 797.9M | 1.2B | 2.2B | ||
| Total Assets | Property, Plant and Equipment - Gross | 162.9M | 172.9M | 209.6M | 193.6M | |
| Depreciation | -72.7M | -80.1M | -87.7M | -61.5M | ||
| Intangible Assets | 19.3M | 20.4M | 22.0M | 24.0M | ||
| Other Assets | 28.9M | 21.7M | 32.1M | 36.9M | ||
| Total Assets | 956.1M | 912.5M | 1.3B | 2.7B | ||
| Liabilities | Accounts Payable | 28.4M | 21.1M | 24.9M | 28.7M | |
| Short Term Debt | 9.0M | 1.2M | 1.6M | 13.7M | ||
| Accrued Expenses | 28.1M | 36.0M | 66.6M | 48.4M | ||
| Other Current Liabilities | 95.4M | 87.3M | 173.1M | 208.6M | ||
| Other Liabilities | 148.9M | 133.8M | 224.7M | 280.3M | ||
| Total Liabilities | Long Term Debt | 472.1M | 587.9M | 605.9M | 633.0M | |
| Deferred Taxes | -- | -- | -- | -290.8M | ||
| Total Liabilities | 755.3M | 812.9M | 903.3M | 1.5B | ||
| Equity | Minority Interest | 0.00 | 0.00 | -11.3M | -58.8M | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 200.8M | 99.6M | 330.9M | 1.0B | ||
| Total Shareholder Equity | 200.8M | 99.6M | 330.9M | 1.0B | ||
| Share Information | Common Shares Outstanding | 120.4M | 121.6M | 125.0M | 137.9M | |
| Addtl. Info. | No data currently available for this section. | |||||
